Centrum Medyczne AMED
About Centrum Medyczne AMED
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
11
Galapagos NV
9
Pfizer
6
Janssen Research & Development, LLC
5
Genentech, Inc.
3
R-Pharm International, LLC
3
Anika Therapeutics, Inc.
2
Bristol-Myers Squibb
2
Celgene
2
Gilead Sciences
2
ACELYRIN Inc.
1
Clinical Trials at Centrum Medyczne AMED
During the past decade, Centrum Medyczne AMED conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 34 clinical trials were completed, i.e. on
average, 69.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 24 clinical trials were completed. i.e. 218.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
2013-07-17
2015-05-14
Completed
599
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)
2013-10-08
2015-05-29
Completed
287
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2013-10-01
2016-04-01
Completed
711
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients
2014-02-25
2023-01-19
Completed
739
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
2014-05-01
2016-05-01
Completed
647
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrum Medyczne AMED" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Galapagos NV" with 9 trials
sponsored, "Pfizer" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Genentech, Inc."
with 5 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne AMED"
#1 collaborator was "Incyte Corporation" with 5 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Centrum Medyczne AMED
According to Clinical.Site data, the most researched conditions in "Centrum Medyczne AMED" are
"Rheumatoid Arthritis" (17 trials), "Psoriatic Arthritis" (5 trials), "Systemic Lupus Erythematosus" (5 trials), "Arthritis, Psoriatic" (3 trials) and "Atopic Dermatitis" (3 trials). Many other conditions were trialed in "Centrum Medyczne AMED" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Medyczne AMED
Most popular intervention types in "Centrum Medyczne AMED" are "Drug" (54 trials), "Biological" (6 trials), "Other" (6 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (35 trials), "Baricitinib" (6 trials), "Filgotinib" (5 trials), "Guselkumab" (3 trials) and "filgotinib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Medyczne AMED
The vast majority of trials in "Centrum Medyczne AMED" are
57 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centrum Medyczne AMED
Currently, there are NaN active trials in "Centrum Medyczne AMED".
undefined are not yet recruiting,
5 are recruiting,
9 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 36 completed trials in Centrum Medyczne AMED,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne AMED, 1 "Phase 1"
clinical trials were conducted, 24 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".